CN

News 2025-06-13

Porton Awarded Gold Medal by EcoVadis, Ranked Among the Top 5% Globally

ESG


Chongqing, China, June 13, 2025 - Porton Pharma Solutions Ltd. (Porton) today announced that its Changshou site, a flagship site for small molecule API manufacturing, has been awarded a gold medal in the latest EcoVadis sustainability rating, ranking in the top 5% of all participating companies. This achievement not only represents a strong endorsement of Porton’s long-term practices in sustainable development, but also highlights its responsibility in the global pharmaceutical industry chain.


As a global leader in sustainability assessment, EcoVadis has provided authoritative rating services for more than 150,000 enterprises. It provides a critical metric for evaluating company's sustainability management system. Porton’s Changshou site scored 79 (out of 100) in the latest assessment, with particularly outstanding performance in Environment and Labor & Human Rights.


As a key participant in the global pharmaceutical value chain, Porton is dedicated to embedding sustainability into its corporate strategy and operations. Porton joined the United Nations Global Compact (UNGC) in 2017, formally pledging to uphold its Ten Principles. In 2024, Porton further expanded its sustainable program portfolio by participating in the Sustainable Markets Initiative (SMI), where it launched a renewable energy procurement project to reduce carbon emissions. This effort was followed by a significant milestone in 2025: Porton's science-based greenhouse gas emissions reductions targets were validated by the Science Based Targets initiative (the SBTi), demonstrating Porton’s determination in sustainable development. Porton also announced its sustainability targets recently, covering energy consumption, water resources, and waste management.


Porton will further advance its sustainability strategy, catalyzing the global pharmaceutical green transition through excellent practice sharing, and expediting the establishment of a resilient green pharmaceutical ecosystem.

Become part of Porton' s community to access personalized insights and resources.
Subscribe for the Newsletter
Porton requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and our commitment to protecting your privacy, please review our Legal Disclaimer Terms and Porton Privacy.

ⓒ 2025 PORTON Legal Notices | Porton Privacy

This website provides information on products tailored for a diverse audience and may include product details or information that are not readily accessible or valid in your country. Please note that we do not accept any responsibility for accessing such information in a manner that may violate any legal processes, regulations, registrations, or usage guidelines in your country of origin.

Become part of Porton' s community to access personalized insights and resources.
Submit
By clicking “Submit” you agree to our Legal Disclaimer terms and conditions and the Porton Privacy and Cookies Policy.

ⓒ 2025 PORTON Legal Notices | Porton Privacy

US: (609) 860-1300
CN: (86) 23-8608-3200